Ashlea Feezel
Neurology with Special Qualifications in Child Neurology · Katy, TXNPI 1306343256
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 159 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$498
- Corium, LLC$325
- Jazz Pharmaceuticals Inc.$314
- Neurelis, Inc.$304
- Supernus Pharmaceuticals, Inc.$297
- Avadel CNS Pharmaceuticals, LLC$283
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,79799%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 22 | $498 |
| Corium, LLC | 15 | $325 |
| Jazz Pharmaceuticals Inc. | 15 | $314 |
| Neurelis, Inc. | 9 | $304 |
| Supernus Pharmaceuticals, Inc. | 15 | $297 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $283 |
| Ironshore Pharmaceuticals Inc. | 11 | $265 |
| Sumitomo Pharma America, Inc. | 12 | $216 |
| Octapharma USA, Inc. | 2 | $139 |
| SK Life Science, Inc. | 6 | $134 |
| Harmony Biosciences LLC | 3 | $116 |
| Catalyst Pharmaceuticals, Inc. | 3 | $111 |
| Livanova USA, Inc. | 4 | $102 |
| Tempus AI, Inc | 3 | $95 |
| AbbVie | 3 | $78 |
| Collegium Pharmaceutical, Inc. | 3 | $68 |
| Otter Pharmaceuticals, LLC | 3 | $60 |
| Vertical Pharmaceuticals, LLC | 2 | $57 |
| Acadia Pharmaceuticals Inc | 2 | $45 |
| Springworks Therapeutics, Inc. | 2 | $45 |
| Aquestive Therapeutics, Inc. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Johnson & Johnson | 1 | $31 |
| Immedica Pharma US, Inc. | 1 | $28 |
| Tris Pharma Inc | 1 | $26 |
| Hospira, Inc. | 1 | $25 |
| Biogen | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Intrabio Inc | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Aucta Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,852 in reported general payments places this provider in the 70th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Katy
- Melissa JonesKaty$10K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Michael PerryFort Worth$162K
- Raphael SchiffmannDallas$88K
- Mauricio Delgado-AyalaDallas$75K
- Kaitlin BatleyDallas$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.